The intestinal epithelial barrier (IEB) is one of the largest interfaces between the
environment and the internal milieu of the body. It is essential to limit the passage of harmful …

The majority of people infected with SARS-CoV-2 fully recovered within a few weeks.
However, a considerable number of patients of different ages still suffer from long-lasting …

Irritable bowel syndrome (IBS) is a highly prevalent, chronic disorder that significantly
reduces patients' quality of life. Advances in diagnostic testing and in therapeutic options for …

Of all microorganisms in the human body, the largest and most complex population resides
in the gastrointestinal (GI) tract. The gut microbiota continuously adapts to the host …

Background & Aims Probiotics can reduce symptoms of irritable bowel syndrome (IBS), but
little is known about their effects on psychiatric comorbidities. We performed a prospective …

Every May, Gastroenterology publishes a supplemen-tary issue devoted to a topic of
particular interest to the science and practice of gastroenterology. Through a collaboration …

Functional gastrointestinal disorders (FGIDs) are diagnosed and classified using the Rome
criteria; the criteria may change over time as new scientific data emerge. The Rome IV was …

As the importance of the gut microbiota in health and disease is increasingly recognized
interest in interventions that can modulate the microbiota and its interactions with its host has …

Objective IBS is associated with an intestinal dysbiosis and faecal microbiota transplantation
(FMT) has been hypothesised to have a positive effect in patients with IBS. We performed a …

Irritable bowel syndrome (IBS) is still a common functional gastrointestinal disease that
presents chronic abdominal symptoms but with a pathophysiology that is not yet fully …